FDA postpones meeting to review over-the-counter birth control pills

In the NewsArticle

Oct 26

AXIOS highlights the FDA’s announcement to postpone its advisory committee meeting for HRA Pharma’s application for an over-the-counter birth control pill.

FDAOTC accessUnited States

Free the Pill

FDA postpones meeting to review over-the-counter birth control pills

U.S. FDA delays panel meeting on Perrigo's OTC birth control pill

FDA delays key advisory committee meeting on OTC birth control